Among patients with Alzheimer disease (AD), a common neuropathologic finding is cerebral amyloid angiopathy (CAA).(1) The main hallmarks of CAA are cerebral microbleeds (CMBs) and cortical superficial siderosis (cSS).(1) Both CMBs and CAA correlate with progressive cognitive impairment in patients with AD.(2,3) This provides further evidence for the dual nature of neurodegenerative diseases such as AD, sustained by the interplay between neurovascular and neurodegenerative processes.(4)
Difrancesco, J., Stanzani, L. (2022). Increased Brain Volume: A Novel Biomarker of Neurodegeneration?. NEUROLOGY, 98(16), 649-650 [10.1212/WNL.0000000000200166].
Increased Brain Volume: A Novel Biomarker of Neurodegeneration?
Difrancesco J. C.;
2022
Abstract
Among patients with Alzheimer disease (AD), a common neuropathologic finding is cerebral amyloid angiopathy (CAA).(1) The main hallmarks of CAA are cerebral microbleeds (CMBs) and cortical superficial siderosis (cSS).(1) Both CMBs and CAA correlate with progressive cognitive impairment in patients with AD.(2,3) This provides further evidence for the dual nature of neurodegenerative diseases such as AD, sustained by the interplay between neurovascular and neurodegenerative processes.(4)
| File | Dimensione | Formato | |
|---|---|---|---|
|
Di Francescp-Stanzani-2022-Neurology-VoR.pdf
Solo gestori archivio
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Tutti i diritti riservati
Dimensione
68.79 kB
Formato
Adobe PDF
|
68.79 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
